HUP0204546A3 - Carbohydrate formulation for enhancement of immune response - Google Patents

Carbohydrate formulation for enhancement of immune response

Info

Publication number
HUP0204546A3
HUP0204546A3 HU0204546A HUP0204546A HUP0204546A3 HU P0204546 A3 HUP0204546 A3 HU P0204546A3 HU 0204546 A HU0204546 A HU 0204546A HU P0204546 A HUP0204546 A HU P0204546A HU P0204546 A3 HUP0204546 A3 HU P0204546A3
Authority
HU
Hungary
Prior art keywords
enhancement
immune response
carbohydrate formulation
carbohydrate
formulation
Prior art date
Application number
HU0204546A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of HUP0204546A2 publication Critical patent/HUP0204546A2/hu
Publication of HUP0204546A3 publication Critical patent/HUP0204546A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
HU0204546A 2000-03-01 2001-02-14 Carbohydrate formulation for enhancement of immune response HUP0204546A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (2)

Publication Number Publication Date
HUP0204546A2 HUP0204546A2 (en) 2003-05-28
HUP0204546A3 true HUP0204546A3 (en) 2003-10-28

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204546A HUP0204546A3 (en) 2000-03-01 2001-02-14 Carbohydrate formulation for enhancement of immune response

Country Status (22)

Country Link
US (2) US20030040492A1 (hu)
EP (1) EP1261355B1 (hu)
JP (1) JP4838477B2 (hu)
KR (1) KR20020081375A (hu)
CN (1) CN1243551C (hu)
AR (1) AR027968A1 (hu)
AT (1) ATE283697T1 (hu)
AU (2) AU2001231746C1 (hu)
BR (1) BR0108828A (hu)
CA (1) CA2400969C (hu)
DE (1) DE60107544T2 (hu)
ES (1) ES2232591T3 (hu)
HK (1) HK1051650A1 (hu)
HU (1) HUP0204546A3 (hu)
IL (1) IL151280A0 (hu)
MX (1) MXPA02008447A (hu)
NO (1) NO20024011D0 (hu)
PL (1) PL365136A1 (hu)
PT (1) PT1261355E (hu)
UA (1) UA73763C2 (hu)
WO (1) WO2001064225A1 (hu)
ZA (1) ZA200207849B (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20100055083A1 (en) * 2006-10-18 2010-03-04 Ray Edward Kowalski Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (en) * 2007-08-24 2010-05-26 Barry Callebaut AG Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110182934A1 (en) 2008-06-13 2011-07-28 N.V. Nutricia Immune system stimulating nutrition
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
JP2012518635A (ja) 2009-02-24 2012-08-16 リター ファーマシューティカルズ インコーポレイテッド プレバイオティック製剤および使用方法
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN106890329A (zh) 2009-07-15 2017-06-27 N·V·努特里奇亚 用于刺激免疫***的不可消化低聚糖的混合物
MY164674A (en) 2009-07-15 2018-01-30 Nutricia Nv Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
ES2545597T3 (es) * 2009-11-12 2015-09-14 Nestec S.A. Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) * 2012-03-28 2015-03-26 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
CN107921058B (zh) * 2015-08-04 2021-04-16 南方糖业股份公司 菊糖对鼻窦炎的预防作用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
MA50086A (fr) 2017-09-08 2020-07-15 Evelo Biosciences Inc Vésicules extracellulaires (ev) bactériennes
JP2020533291A (ja) * 2017-09-08 2020-11-19 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002679A1 (en) * 1985-10-31 1987-05-07 The Australian National University Immunotherapeutic treatment
US5422346A (en) 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
EP0692252B1 (en) * 1994-06-14 2001-04-04 "Raffinerie Tirlemontoise", société anonyme: Use of a composition containing inulin or oligofructose in cancer treatment
EP0856259B1 (en) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Composition for feed use comprising lyophilized live lactic bacteria
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
NO20024011L (no) 2002-08-22
HUP0204546A2 (en) 2003-05-28
MXPA02008447A (es) 2002-12-13
ZA200207849B (en) 2003-12-30
ES2232591T3 (es) 2005-06-01
NO20024011D0 (no) 2002-08-22
BR0108828A (pt) 2002-12-10
JP4838477B2 (ja) 2011-12-14
EP1261355A1 (en) 2002-12-04
EP1261355B1 (en) 2004-12-01
AR027968A1 (es) 2003-04-16
PL365136A1 (en) 2004-12-27
CN1243551C (zh) 2006-03-01
AU2001231746B2 (en) 2004-12-23
AU3174601A (en) 2001-09-12
AU2001231746C1 (en) 2005-10-06
US20030040492A1 (en) 2003-02-27
ATE283697T1 (de) 2004-12-15
UA73763C2 (en) 2005-09-15
DE60107544D1 (de) 2005-01-05
KR20020081375A (ko) 2002-10-26
CA2400969A1 (en) 2001-09-07
WO2001064225A1 (en) 2001-09-07
JP2003533438A (ja) 2003-11-11
US7101553B2 (en) 2006-09-05
PT1261355E (pt) 2005-02-28
CN1422158A (zh) 2003-06-04
IL151280A0 (en) 2003-04-10
CA2400969C (en) 2011-04-19
HK1051650A1 (en) 2003-08-15
US20040191234A1 (en) 2004-09-30
DE60107544T2 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
HUP0204546A3 (en) Carbohydrate formulation for enhancement of immune response
IL218666A0 (en) Enhancement of antibody-medicated immune responses
EG24074A (en) Formulation
AU6158501A (en) Compositions and methods for achieving immune suppression
AU2002242085A1 (en) Methods and compositions useful for stimulating an immune response
GB2364642B (en) Compositions for enhancing the immune response
AU7474100A (en) Methods and compositions for reducing immune response
AUPQ885500A0 (en) Enhancement of products
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
EP1313839A4 (en) IMMUNE POTENTIALIZING COMPOSITIONS
AU6604701A (en) Method to induce the TH1 immune response
EP1300681A4 (en) MEANS FOR TESTING IMMUNE FUNCTION
AU2001236001A1 (en) Immune enhancement compositions and use thereof
GB0129624D0 (en) An item of furniture
GB0014437D0 (en) Immune response stimulation
AU2002364161A8 (en) Enhancement of the immune response using cd36-binding domain
AU2001245815A1 (en) Human immune response proteins
HK1056327A1 (en) Anti-atypical pneumonia decoction
GB0126746D0 (en) Rehydrating formulation
AU2001252907A1 (en) Superantigen enhancement of specific immune responses
EP1179016A4 (en) PARASITE ANTIGENS
TW443499U (en) An improved structure of 3D glasses
GB0026667D0 (en) Lipids promoting immune response
TW444541U (en) Structure of ornaments
PL110499U1 (en) Set of pharmacy furniture